LocumDeck
0161 504 8999
info@nasgp.org.uk
Essential info on patients with T2DM and hypertensions, CVD or heart failure – plus info on CGM.
This is a new guideline from NICE on using dapagliflozin in patients with Type 1 diabetes.
This is a new guideline from NICE on pancreatitis from Sep 2018. Most of it is aimed at secondary care, but there are a few things that are useful for us.
It has been approved for those with 'disabling hypos' and may be particularly useful for children who are more sensitive to nocturnal hypogylcaemia.
© 2025 NASGP
Amelia House, Crescent Road, Worthing, BN11 1QR 0161 504 8999 info@nasgp.org.uk
Design by James Walker | Built by UnitedUs